Our Mission
VosBio is dedicated to expanding respiratory research and discovery through our innovative analytical approach to biological problems. By using an analytical approach, our technology is usable, practical and predictable. Our mission is to provide cutting-edge technologies for enhanced diagnostics and research in the field of respiratory health. Exhaled breath is a non-invasive, comfortable sample that contains the primary source of respiratory infectiousness. In Spiritu Veritas; Truth is in Breath.
Our Story
Founded in 2020 during the Covid-19 pandemic, testing for SARS-CoV-2 was widespread as was a shortage of spin columns to perform the needed purification of clinical samples. Co-founder Doug Gjerde sought a solution for the shortage of spin columns needed to process clinical samples.
At the heart of the collection process is VosCryo™ exhaled breath capture and delivery system. Our device allows for the collection of exhaled breath condensate (EBC) in a fast and efficient way that is as easy as breathing.
​
Our collection method allows users to directly analyze the clinical sample without the need to purify the sample using spin columns using our proprietary chemistry. This analytical approach also looks at the source of respiratory disease.​​
​
Coupled with our state-of-the-art LAMP chemistry, we are able to detect SARS-CoV-2 from EBC in under 15 minutes. This technology is not only fast and easy to use, but it is also much more sensitive and more comfortable to use than any commercially available antigen test. With this platform, testing for respiratory diseases has become much easier and has the potential of becoming the new gold standard of testing worldwide.
​
As a result of this work, we now have a system that can be used to investigate any respiratory illness using any detection method. This include PCR, mass spectrometry, pH, UV spectrometry, ELISA and others.
